Products - GSK US
WEBFind the full list of GSK products available in the United States, including vaccines and specialty medicines for various diseases and conditions. Learn more about GSK's product portfolio and how it prioritizes innovation and access.
Home | GSK US
WEBGSK is a global healthcare company that researches and develops innovative medicines and vaccines. Learn about its initiatives, products, results, and opportunities in the US and worldwide.
Products - GSK
WEBGSK offers a wide range of products to prevent and treat various diseases, from vaccines for RSV, meningitis and flu to specialty medicines for HIV, lupus and cancer. Learn more about GSK's product areas, innovation stories and global health impact.
Products A-Z - GSK
WEBFind a full list of GSK products, including vaccines and medicines, approved in individual countries for specific uses. Filter by product area or browse the alphabetical index to locate the product you are looking for.
Home | GSK
WEBGSK is a global biopharma company that aims to impact the health of 2.5 billion people by 2030. It innovates in four therapeutic areas and prioritizes access, environment and diversity.
At a glance | GSK US
WEBGSK US is a global healthcare company with a portfolio of vaccines, specialty and general medicines. Learn how GSK US is addressing COVID, antimicrobial resistance, pricing, patient assistance, and vaccine hesitancy.
GSKForYou | GSK Patient Assistance Program
WEBGSK for You helps eligible patients access GSK medicines and vaccines in the US. Find out if you qualify for a GSK program and get started by answering a few questions.
List of GSK plc products - Wikipedia
WEBThis is a list of products manufactured by the multinational pharmaceutical, biologics, and vaccines company GSK. It includes brand names, active ingredients, indications, and market availability of various medications and vaccines.
FDA approves GSK’s BENLYSTA as the first medicine for adult …
WEBDec 17, 2020 · GlaxoSmithKline plc (LSE/NYSE: GSK) announced the US Food and Drug Administration (FDA) has approved BENLYSTA (belimumab) for the treatment of adult patients with active lupus nephritis (LN) who are receiving standard therapy.
US FDA approves GSK’s AREXVY, the world’s first respiratory …
WEBMay 3, 2023 · GSK's AREXVY is the first RSV vaccine approved by the US FDA for adults aged 60 and older. It has high efficacy against RSV-LRTD and severe RSV-LRTD, and is expected to launch before the 2023/24 RSV season.